cGxP.wire https://validator.w3.org/feed/docs/rss2.html Akeso AK158D1 Gets NMPA Phase I Clearance for Tumors Biogen Reports Positive Pediatric EMPAVELI Data in C3G Avacta Achieves Clinical Proof of Mechanism for AVA6103 Roche Lunsumio Regimen Improves PFS in Follicular Lymphoma LEO Pharma Gains Positive CHMP Opinion for Anzupgo Bayer Kerendia Wins FDA Approval for Type 1 Diabetes CKD Novo Nordisk Sogroya Gains Positive CHMP Opinion in Europe Johnson & Johnson TECVAYLI Gains Positive CHMP Opinion Roche Ocrevus Gains CHMP Support for Pediatric MS Patients ZBeats Receives FDA Clearance for ZBPro Diagnostic v2.0 Teva Launches LongActingImpact.com for Schizophrenia Care Olatec Therapeutics Adds Parkinson’s Disease Experts Astellas PADCEV and Keytruda Gain Positive CHMP Opinion SkinCure Oncology Reports Higher Skin Cancer Incidence Ultragenyx Wins FDA Approval for FAYUVI Gene Therapy Eirion Therapeutics Reports First-in-Human ET-02 Data Co-Diagnostics Joins WHO Consultation on Global Diagnostics Avenda Health Brings AI Prostate Cancer Mapping to Arizona Array Behavioral Care Launches Rapid Care for Urgent Needs CND Life Sciences Opens New Innovation Lab in Scottsdale 1ST Biotherapeutics and SK Biopharma License Parkinson’s Drug Insilico Opens AI Toolkit for Global Longevity Research Enable Biosciences Gains Brazil Approval for T1D Test Inductive Bio Launches Beacon-2 for AI Drug Discovery Aethlon Medical Merges With North Immunology for NOR-101 Insilico Medicine Advances AI-Designed BTK Cancer Drugs DarioHealth Expands AI Care to 1.5 Million Lives Nuvation Bio IBTROZI Label Updated With Long-Term Data Novo Nordisk Denecimig Shows Tolerability in Hemophilia A Sling Therapeutics Starts Phase 3 Trial of Linsitinib The Braff Group Advises CCR on PhaseWell Partnership Lunai Bioworks Advances AI Chemical Risk Screening Onkos Surgical Expands NanoCept Access for Total Femur Care Dualitas Therapeutics and Roche Launch $1B Bispecific Collaboration Fennec Pharmaceuticals Presents Two-Year Pedmark Data in Japan Bristol Myers Squibb Reports Durable Sotyktu Results in PsA Orbis Medicines and Novo Nordisk Form $1.4B Discovery Deal Synergy Spine Solutions Reports Two-Year Synergy Disc Outcomes Aquestive Resubmits Anaphylm NDA to FDA Kamada Confirms KedRAB Supply Amid Rising U.S. Rabies Demand Nabsys Electronic Genome Mapping Advances Cancer Analysis OncoC4 Receives FDA Fast Track for Cesalatamig Viatris WAKIX Approved in Japan for Sleep Disorders MitoRx to Present MTRX31 Obesity Data at EASD 2026 Nona Biosciences Develops AI Model for Human Antibodies Sunshine Biopharma Advances PLpro Inhibitor Toward IND Curi Bio Advances FDA ISTAND Qualification for BoNT Assay SMSbiotech Advances COPD Program With FDA IND Clearance Aptitude Metrix COVID Test Receives FDA 510(k) Clearance A2 Biotherapeutics Advances A2B395 in Solid Tumors